695
Views
34
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Drug-eluting stents—what should be improved?

, MD, , &
Pages 242-252 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ricardo O Escárcega, Nevin C Baker, Michael J Lipinski, Marco A Magalhaes, Sa'ar Minha, Al-Fazir Omar, Rebecca Torguson & Ron Waksman. (2014) Current application and bioavailability of drug-eluting stents. Expert Opinion on Drug Delivery 11:5, pages 689-709.
Read now
Kai Liu, Guangqing Cao, Xiquan Zhang, Ruifang Liu, Weiwei Zou & Shuming Wu. (2010) Pretreatment with intraluminal rapamycin nanoparticle perfusion inhibits neointimal hyperplasia in a rabbit vein graft model. International Journal of Nanomedicine 5, pages 853-860.
Read now

Articles from other publishers (32)

P. A. Avgustovsky & V. M. Komarovskaya. (2023) Current Trends in Improving Functional Properties of Intravascular Endoprostheses. Science & Technique 22:3, pages 199-207.
Crossref
Zhentao Yu. 2022. Titanium Alloys for Biomedical Development and Applications. Titanium Alloys for Biomedical Development and Applications 125 162 .
O. A. Kashin, K. V. Krukovskii & A. I. Lotkov. (2020) Potential and Capabilities of Porous Silicon as a Material for Intravascular Drug-Eluting Stents: Brief Summary. Inorganic Materials: Applied Research 11:2, pages 287-296.
Crossref
Sarah Akhlaghi, Shahram Rabbani, Sonia Alavi, Azadeh Alinaghi, Fatemeh Radfar, Simin Dadashzadeh & Azadeh Haeri. (2019) Green formulation of curcumin loaded lipid-based nanoparticles as a novel carrier for inhibition of post-angioplasty restenosis. Materials Science and Engineering: C 105, pages 110037.
Crossref
Shigeo IchihashiAlicia Fernández-ColinoFrederic WolfDiana M. Rojas-GonzálezKimihiko KichikawaStefan JockenhoevelThomas Schmitz-RodePetra Mela. (2019) Bio-Based Covered Stents: The Potential of Biologically Derived Membranes. Tissue Engineering Part B: Reviews 25:2, pages 135-151.
Crossref
Azadeh Haeri, Saeed Sadeghian, Shahram Rabbani, Maryam Sotoudeh Anvari, Samaneh Ghassemi, Fatemeh Radfar & Simin Dadashzadeh. (2017) Effective attenuation of vascular restenosis following local delivery of chitosan decorated sirolimus liposomes. Carbohydrate Polymers 157, pages 1461-1469.
Crossref
Azadeh Haeri, Saeed Sadeghian, Shahram Rabbani, Shapour Shirani, Maryam Sotoudeh Anvari & Simin Dadashzadeh. (2017) Physicochemical characteristics of liposomes are decisive for their antirestenosis efficacy following local delivery. Nanomedicine 12:2, pages 131-145.
Crossref
Jing Tang, Yongjia Liu, Bangshang Zhu, Yue Su & Xinyuan Zhu. (2017) Preparation of paclitaxel/chitosan co-assembled core-shell nanofibers for drug-eluting stent. Applied Surface Science 393, pages 299-308.
Crossref
Shu Zhang, Changli Sun, Hai Hu, Yarong He, Yuanchang Yao, Yu Cao & Zhi Zeng. (2016) Effects of Paclitaxel on the Ability of Aspirin and Clopidogrel to Inhibit Platelet Aggregation. Clinical and Applied Thrombosis/Hemostasis 22:7, pages 673-678.
Crossref
Anita C. Thomas, Gianni D. Angelini & Mustafa Zakkar. 2016. Coronary Graft Failure. Coronary Graft Failure 581 593 .
Paninee Chetprayoon, Fumiaki Shima, Michiya Matsusaki, Takami Akagi & Mitsuru Akashi. (2014) Sustainable Release of Paclitaxel from Biodegradable Poly(γ-glutamic acid) Nanoparticles for Treatment of Atherosclerosis. Chemistry Letters 43:11, pages 1767-1769.
Crossref
SHAO-PENG WANG, RONG-CHONG HUANG, HAO ZHU, BO ZHANG, ZHEN-GUO ZHENG, DA YIN, JUN-JIE WANG & XU-CHEN ZHOU. (2013) Safety and efficacy of a non-polymeric paclitaxel-eluting microporous stent in real-world percutaneous coronary intervention. Experimental and Therapeutic Medicine 6:3, pages 811-815.
Crossref
Yasmin Farhatnia, Aaron Tan, Aamir Motiwala, Brian G. Cousins & Alexander M. Seifalian. (2013) Evolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnology. Biotechnology Advances 31:5, pages 524-542.
Crossref
Noora Naghavi, Achala de Mel, Omid Sadeghi Alavijeh, Brian G. Cousins & Alexander M. Seifalian. (2013) Nitric Oxide Donors for Cardiovascular Implant Applications. Small 9:1, pages 22-35.
Crossref
Satoshi Yasuda & Hiroaki Shimokawa. 2013. Chest Pain with Normal Coronary Arteries. Chest Pain with Normal Coronary Arteries 91 99 .
Rami N. Khouzam, Mazen Shaheen, Ramy K. Aziz & Uzoma N. Ibebuogu. (2012) The Important Role of Inflammatory Biomarkers Pre and Post Bare–Metal and Drug–Eluting Stent Implantation. Canadian Journal of Cardiology 28:6, pages 700-705.
Crossref
Filippo MolicaChristian M. MatterFabienne BurgerGraziano PelliSébastien LengletAndreas Zimmer, Pal Pacher & Sabine Steffens. (2012) Cannabinoid receptor CB 2 protects against balloon-induced neointima formation . American Journal of Physiology-Heart and Circulatory Physiology 302:5, pages H1064-H1074.
Crossref
Ryuji Tsuburaya, Satoshi Yasuda, Takashi Shiroto, Yoshitaka Ito, Jun Yi Gao, Kentaro Aizawa, Yoku Kikuchi, Kenta Ito, Jun Takahashi, Hatsue Ishibashi-Ueda & Hiroaki Shimokawa. (2012) Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in vivo: possible involvement of Rho-kinase pathway. European Heart Journal 33:6, pages 791-799.
Crossref
Zong Min Ma, He Yan Dong & Min Qi. (2012) Experimental Study on Fatigue for Stent with Micropores. Advanced Materials Research 479-481, pages 2055-2059.
Crossref
Anita C. Thomas. (2012) Targeted Treatments for Restenosis and Vein Graft Disease. ISRN Vascular Medicine 2012, pages 1-23.
Crossref
Kentaro Aizawa, Satoshi Yasuda, Jun Takahashi, Toru Takii, Yoku Kikuchi, Ryuji Tsuburaya, Yoshitaka Ito, Kenta Ito, Masaharu Nakayama, Morihiko Takeda & Hiroaki Shimokawa. (2012) Involvement of Rho-Kinase Activation in the Pathogenesis of Coronary Hyperconstricting Responses Induced by Drug-Eluting Stents in Patients With Coronary Artery Disease. Circulation Journal 76:11, pages 2552-2560.
Crossref
Ido Levy, Shlomo Magdassi & Daniel Mandler. (2010) Potential induced pH change: Towards electrochemical coating of medical implants by organic nanoparticles. Electrochimica Acta 55:28, pages 8590-8594.
Crossref
Giampaolo Niccoli, Rocco A. Montone, Giuseppe Ferrante & Filippo Crea. (2010) The Evolving Role of Inflammatory Biomarkers in Risk Assessment After Stent Implantation. Journal of the American College of Cardiology 56:22, pages 1783-1793.
Crossref
Irene M. Sroka, Elke H. Heiss, Libor Havlicek, Frank Totzke, Yasmin Aristei, Paul Pechan, Michael H. G. Kubbutat, Miroslav Strnad & Verena M. Dirsch. (2010) A Novel Roscovitine Derivative Potently Induces G 1 -Phase Arrest in Platelet-Derived Growth Factor-BB-Activated Vascular Smooth Muscle Cells . Molecular Pharmacology 77:2, pages 255-261.
Crossref
G. G. Camici, J. Steffel, I. Amanovic, A. Breitenstein, J. Baldinger, S. Keller, T. F. Luscher & F. C. Tanner. (2009) Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. European Heart Journal 31:2, pages 236-242.
Crossref
L. E. Leigh Perkins. (2010) Preclinical Models of Restenosis and Their Application in the Evaluation of Drug-Eluting Stent Systems. Veterinary Pathology 47:1, pages 58-76.
Crossref
Enrico Jandt, Oliver Mutschke, Siavosh Mahboobi, Andrea Uecker, Ronny Platz, Alexander Berndt, Frank-D. Böhmer, Hans R. Figulla & Gerald S. Werner. (2010) Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model. Vascular Pharmacology 52:1-2, pages 55-62.
Crossref
Lars Asmis, Felix C. Tanner, Isabella Sudano, Thomas F. Lüscher & Giovanni G. Camici. (2010) DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents?. Biochemical and Biophysical Research Communications 391:4, pages 1629-1633.
Crossref
Claudia Clavijo, Tobin Strom, Vanessa Moll, Ronald Betts, Yan Ling Zhang, Uwe Christians & Jamie Bendrick-Peart. (2009) Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 877:29, pages 3506-3514.
Crossref
Barry O’Brien & William Carroll. (2009) The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: A review. Acta Biomaterialia 5:4, pages 945-958.
Crossref
Shridhar Hegde & Michelle Schmidt. 2009. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry Volume 44 577 632 .
John G.T. Augoustides, Hynek Riha & Lee A. Fleisher. 2009. Evidence-Based Practice of Anesthesiology. Evidence-Based Practice of Anesthesiology 79 86 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.